Glycosylation of (–)-maackiain by Beauveria bassiana and Cunninghamella echinulata var. elegans
Biocatalysis and Biotransformation
(–)-Maackiain (1) was transformed by Beauveria bassiana and Cunninghamella echinulata var. elegans to yield a new methylglycosylation product, (–)-maackiain-3-O-(4′-O-methyl-β-D-glucopyranoside) (2, 90%) and known trifolirhizin (3, 16%). The kinetics of the two glycosylation reactions was investigated. Additionally, 3 was converted to 2 via 4′-methylation by B. bassiana, which implied that the 4′-methylglycosylation mechanism of (–)-maackiain by B. bassiana is glycosylation followed by methylation. The antioxidant, antifungal, cytotoxic and DNA topoisomerase I inhibition bioactivities of 1, 2 and 3 were tested. Compounds 2 and 3 showed in vitro cytotoxicity against a leukemia cell line (HL-60) with GI50 at 56.3±9.5 and 46.5±5.2 µM, respectively. However, the cytoxicity of 1 was measured as GI50>100 µM.
Yuan, Wei; Wang, Ping; Zhang, Zhizhen; and Li, Shiyou, "Glycosylation of (–)-maackiain by Beauveria bassiana and Cunninghamella echinulata var. elegans" (2010). NCPC Publications and Patents. 43.
Tell us how this article helped you.
Originally published in Biocatalysis and Biotransformation March 2010, Vol. 28, No. 2 , Pages 117-121
SFA authenticated users may access full text here